Pediatric infectious diseases encompass a wide range of illnesses caused by pathogens like bacteria, viruses, fungi, and parasites that affect children. These diseases pose unique challenges due to the developing immune system and different clinical manifestations in pediatric populations. Common pediatric infectious diseases include respiratory infections (such as influenza, respiratory syncytial virus), gastrointestinal infections (rotavirus, norovirus), and vaccine-preventable diseases (measles, mumps, rubella). Bacterial infections like streptococcal infections, urinary tract infections, and skin infections are also prevalent. Diagnosing and managing pediatric infectious diseases require a thorough understanding of age-specific clinical presentations, appropriate laboratory tests, and tailored treatment approaches. Antimicrobial stewardship is crucial to combat antibiotic resistance and ensure effective treatment. Vaccination remains a cornerstone in preventing many pediatric infectious diseases, contributing to improved child health globally. Research focuses on developing new vaccines, understanding host-pathogen interactions, and optimizing treatment strategies to address the unique aspects of pediatric infectious diseases and minimize their impact on children's health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States